Recommended approaches for the laboratory measurement of homocysteine in the diagnosis and monitoring of patients with hyperhomocysteinaemia

Annals of Clinical Biochemistry

Volumn 36, Issue 3, 1999, Pages 372-379

  Moat, S J ^a   Bonham, J R ^a   Tanner, M S ^a   Allen, J C ^a   Powers, H J ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Classical homocystinuria; Remethylation defects; Vascular disease

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; AMINO ACID METABOLISM; AMINO ACID URINE LEVEL; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; MALE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; SCHOOL CHILD; URINARY EXCRETION; VASCULAR DISEASE;

EID: 0033066221     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600311     Document Type: Article

References (23)

1. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985; 37: 1-31
2. Mudd SH, Levy HL, Skovby F. Disorders of transulphuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 1279-1327
3. Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 3129-49
4. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 3111-28
5. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57: 211-5
6. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinaemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55
7. den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?. Lancet 1995; 345: 882-5
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, et al. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-13
9. Bonham JR, Moat SJ, Guthrie PAI, Olpin SE, Tanner MS, Makris M. The thermolabile methylenetetrahydrofolate reductase (MTHFR) mutation a common finding in the UK population. J Inherit Metab Dis 1996; 19: 23
10. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989; 114: 473-501
11. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenetic agent homocysteine. J Clin Invest 1993; 91: 1906-14
12. Loscalzo J. The oxidant stress of hyperhomocysteinaemia. J Clin Invest 1996; 98: 5-7
13. Celermejer DS, Sorenson K, Ryalls M, Robinson J, Thomas O, Leonard JV, et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 1993; 22: 854-8
14. Anderson A, Isakson A, Bratstorm L, Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993; 39: 1590-7
15. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993; 39: 263-71
16. Ueland PM, Refsum H, Stabler S, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79
17. Walker V, Mills GA. Quantitative methods for amino acid analysis in biological fluids. Ann Clin Biochem 1995; 32: 28-57
18. Knox WE. Cystinuria. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The Metabolic Basis of Inherited Disease, 2nd edn. New York: McGraw-Hill, 1960: 1262-82
19. Spaeth GL, Barber GW. Prevalence of homocystinuria among the mentally retarded: evaluation of a specific screening test. Pediatrics 1967; 40: 586-9
20. Stein WH, More S. The free amino acids of human blood plasma. J Biol Chem 1954; 211: 915-26
21. Spaapen LJM, Waterval WAH, Bakker JA, Luijck GJ, Vles JSH. Concerning the kinds of precipitate in normal urine in the presence of picric acid and a new reaction for creatinine [in Dutch]. Tijdschr NVKC 1992; 17: 194-9
22. Jaffe MZ. Detection of hyperhomocystinaemia in early cerebrovascular disease [in German]. Z Physiol Chem 1886; 10: 391-400
23. Wilcken DEL, Wilcken B, Dudman NPB, Tyrell PA. Homocystinuria - the effects of betaine in the treatment of patients not responsive to pyridoxine. New Eng J Med 1983; 309: 448-53